within Pharmacolibrary.Drugs.ATC.S;

model S03AA02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.77,
    Cl             = 0.0006166666666666666,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0013,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0006833333333333333,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>S03AA02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Tetracycline is a broad-spectrum antibiotic from the tetracycline class that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit. It has been widely used for the treatment of various bacterial infections including respiratory tract infections, urinary tract infections, skin infections, and certain sexually transmitted diseases. While it is still used today, resistance has limited its application in some settings.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers after a single oral dose.</p><h4>References</h4><ol><li><p>Mergenhagen, KA, et al., &amp; Russo, TA (2020). Fact versus Fiction: a Review of the Evidence behind Alcohol and Antibiotic Interactions. <i>Antimicrobial agents and chemotherapy</i> 64(3) –. DOI:<a href=\"https://doi.org/10.1128/AAC.02167-19\">10.1128/AAC.02167-19</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/31871085/\">https://pubmed.ncbi.nlm.nih.gov/31871085</a></p></li><li><p>Tao, RE, et al., &amp; Feldman, SR (2023). Oral Tetracycline-Class Drugs in Dermatology: Impact of Food Intake on Absorption and Efficacy. <i>Antibiotics (Basel, Switzerland)</i> 12(7) –. DOI:<a href=\"https://doi.org/10.3390/antibiotics12071152\">10.3390/antibiotics12071152</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/37508248/\">https://pubmed.ncbi.nlm.nih.gov/37508248</a></p></li><li><p>Rodvold, KA, &amp; Pai, MP (2019). Pharmacokinetics and Pharmacodynamics of Oral and Intravenous Omadacycline. <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> 69(Suppl 1) S16–S22. DOI:<a href=\"https://doi.org/10.1093/cid/ciz309\">10.1093/cid/ciz309</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/31367744/\">https://pubmed.ncbi.nlm.nih.gov/31367744</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end S03AA02;
